newsfeed-en
@SachsAssociates
6. Apr 2021 via Twitter
Ana Maiques(@ana_maiques) is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate the brain to help many patients in need. More info @ https://t.co/6YA6CPN7hE pic.twitter.com/vhjc5JXWpB— Sachs Associates (@SachsAssociates) April 6, 2021
@SachsAssociates
6. Apr 2021 via Twitter
Ana Maiques, CEO will be presenting @Neuroelectrics at the upcoming Neuroscience Innovation Forum.Neuroelectrics is pioneering a new therapeutic platform to treat neurological and psychiatric disorders.e-Meet Neuroelectrics at #Sachs_NIFMore info @ https://t.co/6YA6CPN7hE pic.twitter.com/zORcNUI3xX— Sachs Associates (@SachsAssociates) April …
@eurocrowd
6. Apr 2021 via Twitter
📢 We are thrilled to welcome to the network our latest member, @Novoneyra! They are dedicated to preserving Uxío Novoneyra’s legacy and promotion of literature in general. They even created Ith, a project for collective financing of literary projects 👏 https://t.co/l9xg5ylOtD pic.twitter.com/Ap7wTp8Hgm— ECN (@eurocrowd) April 6, 202…
@eurocrowd
1. Apr 2021 via Twitter
What can managing authorities gain from cooperating with #crowdfunding industry? Find answers in this video on the #ficompass study "Crowdfunding and ESF opportunities" we worked on, together with our partners at @EIB, and supported by @EU_Commission. https://t.co/um6fAaI8Kq— ECN (@eurocrowd) April 1, 2021
@SachsAssociates
1. Apr 2021 via Twitter
Don(@donwright113) is President & CEO of @ClarigentHealth, a company that uses machine learning to detect vocal biomarkers of mental health concerns, providing clinical decision support to clinicians. e-Meet Don at #Sachs_NIFMore info @ https://t.co/6YA6CPN7hE pic.twitter.com/JZs99Oi1Q6— Sachs Associates (@SachsAssociates) April 1, 2021
@paymentbanking
31. Mar 2021 via Twitter
if you need a really smart, competent and clever security officer who is sure to find any security hole, you should keep an eye on this young man. and he even has a PhD 👇🏼🎓🚨 https://t.co/sTNNfAH0d8— Payment & Banking (@paymentbanking) March 31, 2021
@SachsAssociates
31. Mar 2021 via Twitter
Don Wright(@donwright113), President & CEO will be presenting @ClarigentHealth at the upcoming Neuroscience Innovation Forum.e-Meet Clarigent Health at #Sachs_NIFMore info @ https://t.co/6YA6CPN7hE pic.twitter.com/UKBipvSgDN— Sachs Associates (@SachsAssociates) March 31, 2021
@SachsAssociates
30. Mar 2021 via Twitter
Rachael Lester(@rachaellester) joined Harpoon Therapeutics in September 2017. She brings nearly 20 years of experience in corporate and commercial strategy, business development and commercial operations. e-Meet Rachael at #Sachs_IOIFMore info @ https://t.co/tMBHnCypoC pic.twitter.com/Ffce7hm2zP— Sachs Associates (@SachsAssociates) March 30, …
@SachsAssociates
30. Mar 2021 via Twitter
Dr. Milton Werner is the President and CEO of Inhibikase Therapeutics, a company developing novel protein kinase inhibitor therapeutics to treat neurodegenerative disease and viral infection inside and outside of the brain. e-Meet Dr. Milton Werner at #Sachs_NIF pic.twitter.com/TY31qyMB47— Sachs Associates (@SachsAssociates) March 30, 2021
@SachsAssociates
29. Mar 2021 via Twitter
Brad Loncar(@bradloncar) is a biotechnology industry investor and CEO of Loncar Investments. He is the creator of two Nasdaq-listed biotech focused exchange-traded funds. e-Meet Brad at #Sachs_IOIFMore info @ https://t.co/tMBHnCypoC pic.twitter.com/x4T6TVkFeZ— Sachs Associates (@SachsAssociates) March 29, 2021